MedPath

Prehabilitation and Rehabilitation in Breast Cancer Surgery Patients - a Pilot Study

Not Applicable
Completed
Conditions
Surgery
Breast Cancer
Prehabilitation
Lifestyle
Rehabilitation
Interventions
Behavioral: Prehabilitation and rehabilitation
Registration Number
NCT06076616
Lead Sponsor
Franciscus Gasthuis
Brief Summary

Prehabilitation and rehabilitation through personalized lifestyle counseling in patients with breast cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Prehabilitation/rehabilitationPrehabilitation and rehabilitationPatients in this arm follow a lifestyle counseling programme starting from diagnosis up to 6 months postoperatively.
Primary Outcome Measures
NameTimeMethod
Recruitment/consent rateFrom baseline to 6 months postoperatively

To estimate patient recruitment/consent rate to the prehabilitation/rehabilitation group Enrolment logs will be recorded for all patients who meet the eligibility criteria. Reasons for non-participation will be recorded. We define a success criterion of 40% of the total number of participants invited to be recruited to the pilot study.

Patient satisfactionFrom baseline to 6 months postoperatively

To estimate patient satisfaction with the programme assessed during three interviews: at four weeks, at three months after surgery and at the end of the study. Satisfaction is defined as: satisfaction with the lifestyle coach, satisfaction with the duration of the intervention, satisfaction with the physical training programme. Patients will be given room for their own input to improve the intervention.

Attendance rateFrom baseline to 6 months postoperatively

To estimate patient attendance, measured by the number of sessions attended out of 10. Reasons for non-attendance will be collected and withdrawals tracked. We will consider an attendance rate of 80% satisfactory

WithdrawalsFrom baseline to 6 months postoperatively

To estimate the number of withdrawals, defined as the proportion of patients who quit the intervention before reaching the primary endpoint (HRQOL at six months after surgery). Information about the reasons for withdrawal will be collected.

Selection biasFrom baseline to 6 months postoperatively

To explore any evidence of selection bias in participants recruited into the study (assessed through participant characteristics at baseline).

Patient adherenceFrom baseline to 6 months postoperatively

To estimate patient adherence monitored with the aid of the wearables. Adherence is defined as at least 150 min of moderate intensity exercise and at least two strength training sessions per week. Exercise instructions are based on the Health Council's exercise guidelines. We will consider an adherence of 70% as satisfactory.

Secondary Outcome Measures
NameTimeMethod
Likely changes in Health Related Quality of Life (HRQOL)Baseline, the day before surgery, 6 months postoperatively

To investigate likely changes in the primary outcome measure HRQOL measured with the EORTC-QLQ-30 questionnaire at six months after surgery.

Likely changes in the number of postoperative complications30 days after surgery

Complications within 30 days after surgery, measured with the Comprehensive Complication Index (CCI)

Likely changes in mean score of the different BREAST-Q scalesThe questionnaire will be administered at enrolment and at six months after surgery.

Measured using the BREAST-Q questionnaire

Likely changes in functional capacity (physical fitness)Baseline, the day before surgery, 6 months postoperatively

Measured using the 6 minute walking test (6MWT)

Likely changes in postoperative functional recoveryThe day after surgery

Measured the day after surgery with the MILAS and DEMMI questionnaires

Likely changes in mean score of the different EORTC-QLQ-30 scales which will be administered at enrolment and six months after surgery.The questionnaire will be administered at enrolment and at six months after surgery.

Measured using the EORTC-QLQ-30 questionnaire

Likely changes in BMIBaseline, the day before surgery, 6 months postoperatively

Body Mass Index

Likely changes in smoking statusMeasured at baseline and 6 months postoperatively

Smoking status (yes/no) as assessed by the primary investigator

Likely changes in mean score of quality of life by means of the EORTC-BR23 questionnaireThe questionnaire will be administered at enrolment and at six months after surgery.

Measured using the EORTC-BR23 questionnaire

Likely changes in mean score of the EQ5D-5L questionnaireThe questionnaire will be administered at enrolment and at six months after surgery.

Measured using the EQ-5D-5L questionnaire

Trial Locations

Locations (1)

Franciscus Gasthuis en Vlietland

🇳🇱

Rotterdam, Zuid-Holland, Netherlands

© Copyright 2025. All Rights Reserved by MedPath